STOCK TITAN

Palisade Bio (PALI) EPS by Year

PALI NASDAQ

Palisade Bio, Inc. lost $0.30 per diluted share in fiscal year 2025. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Palisade Bio, Inc. has filed alongside them.

FY2025 annual
EPS (Diluted) -$0.30
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Sep 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

PALI EPS (Diluted) by Fiscal Year

Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-K
EPS (Diluted)-$0.30-$10.19-$27.01-$247.95-$2546.10-$2790.00

PALI EPS (Diluted) by Quarter

Figures are in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-K
EPS (Diluted)-$0.07-$0.05-$0.05N/A-$0.38-$0.58-$0.47-$0.69-$2.32-$3.32-$4.59-$3.77

What diluted earnings per share means

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.

More Palisade Bio, Inc. financials

Frequently Asked Questions

Palisade Bio, Inc. lost $0.30 per diluted share in fiscal year 2025.

Across the 6 fiscal years this page covers, Palisade Bio, Inc. (PALI) diluted earnings per share went from -$2790.00 in fiscal year 2020 to -$0.30 in fiscal year 2025.

Palisade Bio, Inc. (PALI) reported -$0.07 in diluted earnings per share in Q3 2026.

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Palisade Bio, Inc. (PALI) reported on that line in every period on record.